enadenotucirev
AXP000012.1 · Oncolytic virus
- Platform
- adenovirus (Ad11p/Ad3 group B chimera)
- Originator
- PsiOxus Therapeutics
- Sponsor
- Akamis Bio
Names
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 11 (NCBI Taxonomy 10541)
- Strain
- Ad11p/Ad3 group B chimera (ColoAd1)
- Replication
- conditionally replicating
- Modifications
- Ad11p backbone with Ad3 E2B region; E3 and E4orf4 deletions; selected by directed evolution
- Route
- intravenous, intratumoral, intraperitoneal
- Source
- evidence
Cross-references
- NCI Thesaurus
- C113786
- Wikidata
- Q24975791
- FDA UNII
- KX7ZYR6OQW
Approvals
No regulatory approval recorded.
Clinical trials (5)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | Completed | Phase 1 | 2019-07-29 | 2023-02-24 | 12 | Locally Advanced Rectal Cancer |
| NCT02636036 | Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors | Completed | Phase 1 | 2016-01-25 | 2021-10-08 | 51 | Colorectal Cancer; Epithelial Tumor; Squamous Cell Carcinoma of the Head and Neck |
| NCT02028117 | Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients | Completed | Phase 1 | 2014-06 | 2019-11-19 | 38 | Recurrent Platinum Resistant Ovarian Cancer |
| NCT02053220 | Mechanism of Action Trial of ColoAd1 | Completed | Phase 1 | 2013-06 | 2015-04 | 17 | Resectable Bladder Cancer; Resectable Colon Cancer; Resectable Non-small Cell Lung Cancer; Resectable Renal Cell Carcinoma |
| NCT02028442 | Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients | Completed | Phase 1/2 | 2012-09-20 | 2016-04-29 | 61 | Metastatic Bladder Cancer; Metastatic Colorectal Cancer; Solid Tumours of Epithelial Origin |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 36897458 | A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies. | Investigational new drugs | 2023 | cited by trial NCT02028117 |
| PMID 37094988 | Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE). | Journal for immunotherapy of cancer | 2023 | cited by trial NCT02636036 |
| PMID 34893524 | Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial. | Journal for immunotherapy of cancer | 2021 | cited by trial NCT02028117 |
| PMID 32532291 | A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR). | Radiation oncology (London, England) | 2020 | cited by trial NCT03916510 |
| PMID 30691536 | A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE). | Journal for immunotherapy of cancer | 2019 | cited by trial NCT02028442 |
| PMID 28923104 | Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. | Journal for immunotherapy of cancer | 2017 | cited by trial NCT02053220 |
Unconfirmed matches (2)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 39212577 | Development and internal validation of an artificial intelligence-assisted bowel sounds auscultation system to predict early enteral nutrition-associated diarrhoea in acute pancreatitis: a prospective observational study. | British journal of hospital medicine (London, England : 2005) | 2024 | name in abstract: EnAd |
| PMID 35350674 | Successful Treatment of Pancreatic Fistula Following Surgery for Congenital Biliary Dilatation with Endoscopic Ultrasound-Guided Transduodenal Drainage. | Case reports in gastroenterology | 2022 | name in abstract: EnAd |
Other papers
Preclinical studies, reviews and other papers that name it, newest 100 shown.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 42700728 | Bioactive vitamin E-NAD+ conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress. | Biomaterials | 2027 | name in title: EnAd |
| PMID 42575880 | Hypoxia increases the activity of oncolytic adenoviruses through HIF-2α-stimulated E1A expression. | Signal transduction and targeted therapy | 2026 | name in abstract: enadenotucirev |
| PMID 42837725 | Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions. | Seminars in oncology | 2026 | name in abstract: enadenotucirev |
| PMID 41358276 | Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration. | Journal of immunotherapy and precision oncology | 2025 | name in abstract: enadenotucirev |
| PMID 37921471 | Toward the understanding of DSG2 and CD46 interaction with HAdV-11 fiber, a super-complex analysis. | Journal of virology | 2023 | name in abstract: enadenotucirev |
| PMID 32195317 | NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer. | Molecular therapy oncolytics | 2020 | name in abstract: enadenotucirev |
| PMID 32224979 | External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase. | Cancers | 2020 | name in title: enadenotucirev |
| PMID 32244697 | Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion. | Cancers | 2020 | name in abstract: enadenotucirev |
| PMID 30487139 | Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells. | Cancer research | 2019 | name in abstract: enadenotucirev |
| PMID 30874432 | Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo. | Bioconjugate chemistry | 2019 | name in title: enadenotucirev |
| PMID 31753017 | Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples. | Journal for immunotherapy of cancer | 2019 | name in abstract: enadenotucirev |
| PMID 31890865 | Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation. | Molecular therapy oncolytics | 2019 | name in title: enadenotucirev |
| PMID 29898782 | Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. | Journal for immunotherapy of cancer | 2018 | name in abstract: enadenotucirev |
| PMID 30449733 | An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells. | Cancer research | 2018 | name in abstract: enadenotucirev |
| PMID 28260622 | Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer. | Virology | 2017 | name in title: enadenotucirev |
| PMID 28345021 | Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators. | Molecular therapy oncolytics | 2017 | name in title: enadenotucirev |
| PMID 28480328 | Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus. | Molecular therapy oncolytics | 2017 | name in title: enadenotucirev |
| PMID 28542292 | Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes. | PloS one | 2017 | name in abstract: enadenotucirev |
| PMID 28634161 | Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies. | EMBO molecular medicine | 2017 | name in abstract: enadenotucirev |
| PMID 26708004 | Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth. | Molecular therapy : the journal of the American Society of Gene Therapy | 2016 | name in title: enadenotucirev |
| PMID 24553347 | Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood. | Gene therapy | 2014 | name in title: ColoAd1 |
| PMID 22312363 | Oncolytic viruses: the power of directed evolution. | Advances in virology | 2012 | name in abstract: ColoAd1 |
| PMID 23151443 | Human vaccines: news. | Human vaccines & immunotherapeutics | 2012 | name in abstract: ColoAd1 |
| PMID 19458647 | In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer. | Gene therapy | 2009 | name in title: ColoAd1 |
| PMID 18560559 | Directed evolution generates a novel oncolytic virus for the treatment of colon cancer. | PloS one | 2008 | name in abstract: ColoAd1 |
Unconfirmed matches (75)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 42050596 | Tracking pathogen-related markers with eDNA in natural areas: how environmental factors shape surveillance strategies. | Veterinary research | 2026 | name in abstract: EnAd |
| PMID 42461371 | Altered gene expression in the liver and small intestine of horses with equine neuroaxonal dystrophy. | Equine veterinary journal | 2026 | name in abstract: EnAd |
| PMID 42523671 | Development and validation of an interpretable machine-learning model for enteral nutrition-associated diarrhea in critically ill patients with ischemic stroke: a retrospective cohort study. | Frontiers in nutrition | 2026 | name in abstract: EnAd |
| PMID 42666235 | An evaluation based on explainable machine learning: analysis of risk factors for enteral nutrition-related diarrhea in patients with severe stroke. | Frontiers in nutrition | 2026 | name in abstract: EnAd |
| PMID 42676407 | Development and validation of an interpretable machine learning model for predicting enteral nutrition-associated diarrhea in ICU patients: a multicenter study. | Frontiers in nutrition | 2026 | name in abstract: EnAd |
| PMID 39107138 | Effectiveness of a novel artificial intelligence-assisted colonoscopy system for adenoma detection: a prospective, propensity score-matched, non-randomized controlled study in Korea. | Clinical endoscopy | 2025 | name in abstract: EnAd |
| PMID 40107998 | Extracellular NAD+ levels are associated with CD203a expression on Th17 cells and predict long-term recurrence-free survival in hepatocellular carcinoma. | Journal of cancer research and clinical oncology | 2025 | name in abstract: EnAd |
| PMID 40635902 | Machine learning-based predictive model for enteral nutrition-associated diarrhea in ICU patients and its nursing applications. | Frontiers in nutrition | 2025 | name in abstract: EnAd |
| PMID 40707945 | Knowledge, attitudes, and behaviors of ICU nurses for enteral nutrition-related diarrhea management: a cross-sectional study. | BMC nursing | 2025 | name in abstract: EnAd |
| PMID 40912280 | Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy. | American journal of veterinary research | 2025 | name in abstract: EnAd |
| PMID 41310685 | Wildlife risk mitigation protocols reduce risk species visits and pathogen marker detection in open-air farms. | Veterinary research | 2025 | name in abstract: EnAd |
| PMID 37937700 | Genetic polymorphisms in vitamin E transport genes as determinants for risk of equine neuroaxonal dystrophy. | Journal of veterinary internal medicine | 2024 | name in abstract: EnAd |
| PMID 38095342 | Clinical and histopathological features in horses with neuroaxonal degeneration: 100 cases (2017-2021). | Journal of veterinary internal medicine | 2024 | name in abstract: EnAd |
| PMID 38404274 | [Effect analysis of information-guided enteral nutrition-associated diarrhea treatment process in patients with chronic obstructive pulmonary disease undergoing continuous non-invasive assisted ventilation: a mixed cohort study of pre- and post-control]. | Zhonghua wei zhong bing ji jiu yi xue | 2024 | name in abstract: EnAd |
| PMID 38613444 | Equine neuroaxonal dystrophy/degenerative myeloencephalopathy in Gypsy Vanner horses. | Journal of veterinary internal medicine | 2024 | name in abstract: EnAd |
| PMID 38669583 | Clinicopathological and pedigree investigation of a novel spinocerebellar neurological disease in juvenile Quarter Horses in North America. | Journal of veterinary internal medicine | 2024 | name in abstract: EnAd |
| PMID 38693779 | Redox signaling and oxidative stress in systemic acquired resistance. | Journal of experimental botany | 2024 | name in abstract: EnAd |
| PMID 38734404 | Current insights into equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy. | Veterinary journal (London, England : 1997) | 2024 | name in abstract: EnAd |
| PMID 38895984 | Evolution of fungal tuberculosis necrotizing toxin (TNT) domain-containing enzymes reveals divergent adaptations to enhance NAD cleavage. | Protein science : a publication of the Protein Society | 2024 | name in abstract: EnAd |
| PMID 38960891 | Real-World Application of Artificial Intelligence for Detecting Pathologic Gastric Atypia and Neoplastic Lesions. | Journal of gastric cancer | 2024 | name in abstract: EnAd |
| PMID 39143151 | Extracellular NAD+ response to post-hepatectomy liver failure: bridging preclinical and clinical findings. | Communications biology | 2024 | name in abstract: EnAd |
| PMID 39252595 | Nucleotides and nucleotide derivatives as signal molecules in plants. | Journal of experimental botany | 2024 | name in abstract: EnAd |
| PMID 39554755 | One Health Farming: Noninvasive monitoring reveals links between farm vertebrate richness and pathogen markers in outdoor hoofstock. | One health (Amsterdam, Netherlands) | 2024 | name in abstract: EnAd |
| PMID 36929645 | Cerebrospinal fluid and serum proteomic profiles accurately distinguish neuroaxonal dystrophy from cervical vertebral compressive myelopathy in horses. | Journal of veterinary internal medicine | 2023 | name in abstract: EnAd |
| PMID 37371238 | Expressed Beliefs about the Cause of Pain in a Pediatric Population: A Qualitative Study. | Children (Basel, Switzerland) | 2023 | name in abstract: EnAd |
| PMID 37396638 | Ligand recognition and signal transduction by lectin receptor-like kinases in plant immunity. | Frontiers in plant science | 2023 | name in abstract: EnAd |
| PMID 37891163 | N-hydroxypipecolic acid triggers systemic acquired resistance through extracellular NAD(P). | Nature communications | 2023 | name in abstract: EnAd |
| PMID 38259852 | Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational research. | Frontiers in medicine | 2023 | name in abstract: EnAd |
| PMID 33969539 | Serum and cerebrospinal fluid phosphorylated neurofilament heavy protein concentrations in equine neurodegenerative diseases. | Equine veterinary journal | 2022 | name in abstract: EnAd |
| PMID 35811203 | Equine Neuroaxonal Dystrophy and Degenerative Myeloencephalopathy. | The Veterinary clinics of North America. Equine practice | 2022 | name in abstract: EnAd |
| PMID 33527764 | Determination of vitamin E and its metabolites in equine urine using liquid chromatography-mass spectrometry. | Drug testing and analysis | 2021 | name in abstract: EnAd |
| PMID 34001129 | A qualitative exploration of barriers in accessing community pharmacy services for persons with disability in Addis Ababa, Ethiopia: a cross sectional phenomenological study. | BMC health services research | 2021 | name in abstract: EnAd |
| PMID 34061609 | Postmortem diagnoses of spinal ataxia in 316 horses in California. | Journal of the American Veterinary Medical Association | 2021 | name in abstract: EnAd |
| PMID 34097876 | SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure. | The Journal of biological chemistry | 2021 | name in abstract: EnAd |
| PMID 34331715 | Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy. | Journal of veterinary internal medicine | 2021 | name in abstract: EnAd |
| PMID 31936863 | Genome-Wide Association Study and Subsequent Exclusion of ATCAY as a Candidate Gene Involved in Equine Neuroaxonal Dystrophy Using Two Animal Models. | Genes | 2020 | name in abstract: EnAd |
| PMID 32024306 | New Insight into Plant Signaling: Extracellular ATP and Uncommon Nucleotides. | Cells | 2020 | name in abstract: EnAd |
| PMID 32735345 | Extracellular metabolism of the enteric inhibitory neurotransmitter β-nicotinamide adenine dinucleotide (β-NAD) in the murine colon. | The Journal of physiology | 2020 | name in abstract: EnAd |
| PMID 32828421 | Identification of the first noncompetitive SARM1 inhibitors. | Bioorganic & medicinal chemistry | 2020 | name in abstract: EnAd |
| PMID 30705767 | Aging and End Stage Renal Disease Cause A Decrease in Absolute Circulating Lymphocyte Counts with A Shift to A Memory Profile and Diverge in Treg Population. | Aging and disease | 2019 | name in abstract: EnAd |
| PMID 30794798 | Thermodynamic analysis of remote substrate binding energy in 3α-hydroxysteroid dehydrogenase/carbonyl reductase catalysis. | Chemico-biological interactions | 2019 | name in abstract: EnAd |
| PMID 31491999 | Previously Identified Genetic Variants in ADGRL3 Are not Associated with Risk for Equine Degenerative Myeloencephalopathy across Breeds. | Genes | 2019 | name in abstract: EnAd |
| PMID 31641112 | Extracellular pyridine nucleotides trigger plant systemic immunity through a lectin receptor kinase/BAK1 complex. | Nature communications | 2019 | name in abstract: EnAd |
| PMID 30133798 | Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy. | Journal of veterinary internal medicine | 2018 | name in abstract: EnAd |
| PMID 30356715 | Exogenous Nicotinamide Adenine Dinucleotide Induces Resistance to Citrus Canker in Citrus. | Frontiers in plant science | 2018 | name in abstract: EnAd |
| PMID 30429455 | Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD. | Cell death & disease | 2018 | name in abstract: EnAd |
| PMID 28722654 | A lectin receptor kinase as a potential sensor for extracellular nicotinamide adenine dinucleotide in Arabidopsis thaliana. | eLife | 2017 | name in abstract: EnAd |
| PMID 29035673 | Extracellular pyridine nucleotides as immune elicitors in arabidopsis. | Plant signaling & behavior | 2017 | name in abstract: EnAd |
| PMID 27751910 | Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes. | Free radical biology & medicine | 2016 | name in abstract: EnAd |
| PMID 22670756 | Expression of the human NAD(P)-metabolizing ectoenzyme CD38 compromises systemic acquired resistance in Arabidopsis. | Molecular plant-microbe interactions : MPMI | 2012 | name in abstract: EnAd |
| PMID 21917911 | Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. | Molecular pharmacology | 2011 | name in abstract: EnAd |
| PMID 18798871 | Extracellular pyridine nucleotides induce PR gene expression and disease resistance in Arabidopsis. | The Plant journal : for cell and molecular biology | 2009 | name in abstract: EnAd |
| PMID 15581588 | Effects of pressure on deuterium isotope effects of yeast alcohol dehydrogenase using alternative substrates. | Archives of biochemistry and biophysics | 2005 | name in abstract: EnAd |
| PMID 12785808 | Reversible, electrochemical interconversion of NADH and NAD+ by the catalytic (Ilambda) subcomplex of mitochondrial NADH:ubiquinone oxidoreductase (complex I). | Journal of the American Chemical Society | 2003 | name in abstract: EnAd |
| PMID 11170403 | Effect of pressure on deuterium isotope effects of formate dehydrogenase. | Biochemistry | 2001 | name in abstract: EnAd |
| PMID 11306059 | Ternary complexes of liver alcohol dehydrogenase. | Chemico-biological interactions | 2001 | name in abstract: EnAd |
| PMID 11306060 | Bioinorganic and bioorganic studies of liver alcohol dehydrogenase. | Chemico-biological interactions | 2001 | name in abstract: EnAd |
| PMID 11368521 | Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene. | Archives of biochemistry and biophysics | 2001 | name in abstract: EnAd |
| PMID 11495586 | Synthesis, mechanism of action, and antiviral activity of a new series of covalent mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase. | Journal of medicinal chemistry | 2001 | name in abstract: EnAd |
| PMID 10969022 | Effects of high pressure on solvent isotope effects of yeast alcohol dehydrogenase. | Biophysical journal | 2000 | name in abstract: EnAd |
| PMID 11106503 | Mechanisms of inactivation of human S-adenosylhomocysteine hydrolase by 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosines. | Biochemistry | 2000 | name in abstract: EnAd |
| PMID 10210192 | Relationships within the aldehyde dehydrogenase extended family. | Protein science : a publication of the Protein Society | 1999 | name in abstract: EnAd |
| PMID 10360944 | Effects of pressure on the kinetics of capture by yeast alcohol dehydrogenase. | Biochemistry | 1999 | name in abstract: EnAd |
| PMID 10441145 | Kinetic study of the catalytic mechanism of mannitol dehydrogenase from Pseudomonas fluorescens. | Biochemistry | 1999 | name in abstract: EnAd |
| PMID 10493822 | Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. | Biochemistry | 1999 | name in abstract: EnAd |
| PMID 9748360 | Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine). | Journal of medicinal chemistry | 1998 | name in abstract: EnAd |
| PMID 9825307 | The mechanism of inactivation of S-adenosylhomocysteine hydrolase by fluorinated analogs of 5'-methylthioadenosine. | Journal of enzyme inhibition | 1998 | name in abstract: EnAd |
| PMID 9063465 | D-2-hydroxy-4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus. I. Kinetic mechanism and pH dependence of kinetic parameters, coenzyme binding and substrate inhibition. | European journal of biochemistry | 1997 | name in abstract: EnAd |
| PMID 8992395 | [Method and application limitations of decision support systems in acute pancreatitis]. | Minerva chirurgica | 1996 | name in abstract: EnAd |
| PMID 8218182 | Alternative pathways and reactions of benzyl alcohol and benzaldehyde with horse liver alcohol dehydrogenase. | Biochemistry | 1993 | name in abstract: EnAd |
| PMID 2043614 | Hydrophobic anion activation of human liver chi chi alcohol dehydrogenase. | Biochemistry | 1991 | name in abstract: EnAd |
| PMID 2161681 | Rate constants for a mechanism including intermediates in the interconversion of ternary complexes by horse liver alcohol dehydrogenase. | Biochemistry | 1990 | name in abstract: EnAd |
| PMID 2846570 | Studies on the electron transfer pathway, topography of iron-sulfur centers, and site of coupling in NADH-Q oxidoreductase. | The Journal of biological chemistry | 1988 | name in abstract: EnAd |
| PMID 3167032 | Mechanism of binding of horse liver alcohol dehydrogenase and nicotinamide adenine dinucleotide. | Biochemistry | 1988 | name in abstract: EnAd |
| PMID 3401491 | Fluorescence stopped-flow studies on the binding of 1,N6-etheno-NAD to bovine liver glutamate dehydrogenase. | Biochimica et biophysica acta | 1988 | name in abstract: EnAd |
NIH grants
No confirmed grants yet.
Unconfirmed matches (1)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| F32AI194558 | Control of CD8+ T cell Memory Homeostasis via Extracellular Damage Sensors ARTC2 & P2RX7 | UNIVERSITY OF MINNESOTA | VALENTE, WILLIAM JOSEPH | 2025–2025 | name in abstract: EnAd |
Notes
Unarmed backbone; selected by directed evolution and first called ColoAd1. PsiOxus renamed itself Akamis Bio in January 2023. The armed T-SIGn vectors NG-350A and NG-641 are separate constructs, so separate programs (not entered here).
How to cite
enadenotucirev (AXP000012.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000012.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.